Request for Covid-19 Impact Assessment of this Report
The United States Purpura Therapy Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Purpura Therapy Drugs market, reaching US$ million by the year 2028. As for the Europe Purpura Therapy Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Purpura Therapy Drugs players cover Bristol-Myers Squibb Company, Pfizer Inc, GlaxoSmithKline Plc, and Novartis AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Purpura Therapy Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Allergic Purpura
Thrombocytopenic Purpura
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Use
Clinic Use
Household
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bristol-Myers Squibb Company
Pfizer Inc
GlaxoSmithKline Plc
Novartis AG
Hovione
Sanofi Winthrop Industrie S.A.
Hoffman-L Roche
Amgen Inc
Grifols Biologicals Inc
Ablynx NV
Biogen Inc
KM Biologics
Lee's Pharmaceutical Holdings Ltd
Omeros Corp
Takeda
Roch
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Purpura Therapy Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Purpura Therapy Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Purpura Therapy Drugs by Country/Region, 2017, 2022 & 2028
2.2 Purpura Therapy Drugs Segment by Type
2.2.1 Allergic Purpura
2.2.2 Thrombocytopenic Purpura
2.3 Purpura Therapy Drugs Sales by Type
2.3.1 Global Purpura Therapy Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Purpura Therapy Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Purpura Therapy Drugs Sale Price by Type (2017-2022)
2.4 Purpura Therapy Drugs Segment by Application
2.4.1 Hospital Use
2.4.2 Clinic Use
2.4.3 Household
2.4.4 Other
2.5 Purpura Therapy Drugs Sales by Application
2.5.1 Global Purpura Therapy Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Purpura Therapy Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Purpura Therapy Drugs Sale Price by Application (2017-2022)
3 Global Purpura Therapy Drugs by Company
3.1 Global Purpura Therapy Drugs Breakdown Data by Company
3.1.1 Global Purpura Therapy Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Purpura Therapy Drugs Sales Market Share by Company (2020-2022)
3.2 Global Purpura Therapy Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Purpura Therapy Drugs Revenue by Company (2020-2022)
3.2.2 Global Purpura Therapy Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Purpura Therapy Drugs Sale Price by Company
3.4 Key Manufacturers Purpura Therapy Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Purpura Therapy Drugs Product Location Distribution
3.4.2 Players Purpura Therapy Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Purpura Therapy Drugs by Geographic Region
4.1 World Historic Purpura Therapy Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Purpura Therapy Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Purpura Therapy Drugs Annual Revenue by Geographic Region
4.2 World Historic Purpura Therapy Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Purpura Therapy Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Purpura Therapy Drugs Annual Revenue by Country/Region
4.3 Americas Purpura Therapy Drugs Sales Growth
4.4 APAC Purpura Therapy Drugs Sales Growth
4.5 Europe Purpura Therapy Drugs Sales Growth
4.6 Middle East & Africa Purpura Therapy Drugs Sales Growth
5 Americas
5.1 Americas Purpura Therapy Drugs Sales by Country
5.1.1 Americas Purpura Therapy Drugs Sales by Country (2017-2022)
5.1.2 Americas Purpura Therapy Drugs Revenue by Country (2017-2022)
5.2 Americas Purpura Therapy Drugs Sales by Type
5.3 Americas Purpura Therapy Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Purpura Therapy Drugs Sales by Region
6.1.1 APAC Purpura Therapy Drugs Sales by Region (2017-2022)
6.1.2 APAC Purpura Therapy Drugs Revenue by Region (2017-2022)
6.2 APAC Purpura Therapy Drugs Sales by Type
6.3 APAC Purpura Therapy Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Purpura Therapy Drugs by Country
7.1.1 Europe Purpura Therapy Drugs Sales by Country (2017-2022)
7.1.2 Europe Purpura Therapy Drugs Revenue by Country (2017-2022)
7.2 Europe Purpura Therapy Drugs Sales by Type
7.3 Europe Purpura Therapy Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Purpura Therapy Drugs by Country
8.1.1 Middle East & Africa Purpura Therapy Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Purpura Therapy Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Purpura Therapy Drugs Sales by Type
8.3 Middle East & Africa Purpura Therapy Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Purpura Therapy Drugs
10.3 Manufacturing Process Analysis of Purpura Therapy Drugs
10.4 Industry Chain Structure of Purpura Therapy Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Purpura Therapy Drugs Distributors
11.3 Purpura Therapy Drugs Customer
12 World Forecast Review for Purpura Therapy Drugs by Geographic Region
12.1 Global Purpura Therapy Drugs Market Size Forecast by Region
12.1.1 Global Purpura Therapy Drugs Forecast by Region (2023-2028)
12.1.2 Global Purpura Therapy Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Purpura Therapy Drugs Forecast by Type
12.7 Global Purpura Therapy Drugs Forecast by Application
13 Key Players Analysis
13.1 Bristol-Myers Squibb Company
13.1.1 Bristol-Myers Squibb Company Company Information
13.1.2 Bristol-Myers Squibb Company Purpura Therapy Drugs Product Offered
13.1.3 Bristol-Myers Squibb Company Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bristol-Myers Squibb Company Main Business Overview
13.1.5 Bristol-Myers Squibb Company Latest Developments
13.2 Pfizer Inc
13.2.1 Pfizer Inc Company Information
13.2.2 Pfizer Inc Purpura Therapy Drugs Product Offered
13.2.3 Pfizer Inc Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Pfizer Inc Main Business Overview
13.2.5 Pfizer Inc Latest Developments
13.3 GlaxoSmithKline Plc
13.3.1 GlaxoSmithKline Plc Company Information
13.3.2 GlaxoSmithKline Plc Purpura Therapy Drugs Product Offered
13.3.3 GlaxoSmithKline Plc Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 GlaxoSmithKline Plc Main Business Overview
13.3.5 GlaxoSmithKline Plc Latest Developments
13.4 Novartis AG
13.4.1 Novartis AG Company Information
13.4.2 Novartis AG Purpura Therapy Drugs Product Offered
13.4.3 Novartis AG Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis AG Main Business Overview
13.4.5 Novartis AG Latest Developments
13.5 Hovione
13.5.1 Hovione Company Information
13.5.2 Hovione Purpura Therapy Drugs Product Offered
13.5.3 Hovione Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hovione Main Business Overview
13.5.5 Hovione Latest Developments
13.6 Sanofi Winthrop Industrie S.A.
13.6.1 Sanofi Winthrop Industrie S.A. Company Information
13.6.2 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Product Offered
13.6.3 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sanofi Winthrop Industrie S.A. Main Business Overview
13.6.5 Sanofi Winthrop Industrie S.A. Latest Developments
13.7 Hoffman-L Roche
13.7.1 Hoffman-L Roche Company Information
13.7.2 Hoffman-L Roche Purpura Therapy Drugs Product Offered
13.7.3 Hoffman-L Roche Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hoffman-L Roche Main Business Overview
13.7.5 Hoffman-L Roche Latest Developments
13.8 Amgen Inc
13.8.1 Amgen Inc Company Information
13.8.2 Amgen Inc Purpura Therapy Drugs Product Offered
13.8.3 Amgen Inc Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Amgen Inc Main Business Overview
13.8.5 Amgen Inc Latest Developments
13.9 Grifols Biologicals Inc
13.9.1 Grifols Biologicals Inc Company Information
13.9.2 Grifols Biologicals Inc Purpura Therapy Drugs Product Offered
13.9.3 Grifols Biologicals Inc Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Grifols Biologicals Inc Main Business Overview
13.9.5 Grifols Biologicals Inc Latest Developments
13.10 Ablynx NV
13.10.1 Ablynx NV Company Information
13.10.2 Ablynx NV Purpura Therapy Drugs Product Offered
13.10.3 Ablynx NV Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Ablynx NV Main Business Overview
13.10.5 Ablynx NV Latest Developments
13.11 Biogen Inc
13.11.1 Biogen Inc Company Information
13.11.2 Biogen Inc Purpura Therapy Drugs Product Offered
13.11.3 Biogen Inc Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Biogen Inc Main Business Overview
13.11.5 Biogen Inc Latest Developments
13.12 KM Biologics
13.12.1 KM Biologics Company Information
13.12.2 KM Biologics Purpura Therapy Drugs Product Offered
13.12.3 KM Biologics Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 KM Biologics Main Business Overview
13.12.5 KM Biologics Latest Developments
13.13 Lee's Pharmaceutical Holdings Ltd
13.13.1 Lee's Pharmaceutical Holdings Ltd Company Information
13.13.2 Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Product Offered
13.13.3 Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Lee's Pharmaceutical Holdings Ltd Main Business Overview
13.13.5 Lee's Pharmaceutical Holdings Ltd Latest Developments
13.14 Omeros Corp
13.14.1 Omeros Corp Company Information
13.14.2 Omeros Corp Purpura Therapy Drugs Product Offered
13.14.3 Omeros Corp Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Omeros Corp Main Business Overview
13.14.5 Omeros Corp Latest Developments
13.15 Takeda
13.15.1 Takeda Company Information
13.15.2 Takeda Purpura Therapy Drugs Product Offered
13.15.3 Takeda Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Takeda Main Business Overview
13.15.5 Takeda Latest Developments
13.16 Roch
13.16.1 Roch Company Information
13.16.2 Roch Purpura Therapy Drugs Product Offered
13.16.3 Roch Purpura Therapy Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Roch Main Business Overview
13.16.5 Roch Latest Developments
14 Research Findings and Conclusion
Table 1. Purpura Therapy Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Purpura Therapy Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Allergic Purpura
Table 4. Major Players of Thrombocytopenic Purpura
Table 5. Global Purpura Therapy Drugs Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Purpura Therapy Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Purpura Therapy Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Purpura Therapy Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Purpura Therapy Drugs Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Purpura Therapy Drugs Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Purpura Therapy Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Purpura Therapy Drugs Revenue by Application (2017-2022)
Table 13. Global Purpura Therapy Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Purpura Therapy Drugs Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Purpura Therapy Drugs Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Purpura Therapy Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Purpura Therapy Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Purpura Therapy Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Purpura Therapy Drugs Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Purpura Therapy Drugs Producing Area Distribution and Sales Area
Table 21. Players Purpura Therapy Drugs Products Offered
Table 22. Purpura Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Purpura Therapy Drugs Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Purpura Therapy Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Purpura Therapy Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Purpura Therapy Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Purpura Therapy Drugs Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Purpura Therapy Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Purpura Therapy Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Purpura Therapy Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Purpura Therapy Drugs Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Purpura Therapy Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Purpura Therapy Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Purpura Therapy Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Purpura Therapy Drugs Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Purpura Therapy Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Purpura Therapy Drugs Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Purpura Therapy Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Purpura Therapy Drugs Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Purpura Therapy Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Purpura Therapy Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Purpura Therapy Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Purpura Therapy Drugs Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Purpura Therapy Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Purpura Therapy Drugs Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Purpura Therapy Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Purpura Therapy Drugs Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Purpura Therapy Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Purpura Therapy Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Purpura Therapy Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Purpura Therapy Drugs Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Purpura Therapy Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Purpura Therapy Drugs Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Purpura Therapy Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Purpura Therapy Drugs Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Purpura Therapy Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Purpura Therapy Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Purpura Therapy Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Purpura Therapy Drugs Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Purpura Therapy Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Purpura Therapy Drugs Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Purpura Therapy Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Purpura Therapy Drugs
Table 66. Key Market Challenges & Risks of Purpura Therapy Drugs
Table 67. Key Industry Trends of Purpura Therapy Drugs
Table 68. Purpura Therapy Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Purpura Therapy Drugs Distributors List
Table 71. Purpura Therapy Drugs Customer List
Table 72. Global Purpura Therapy Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Purpura Therapy Drugs Sales Market Forecast by Region
Table 74. Global Purpura Therapy Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Purpura Therapy Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Purpura Therapy Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Purpura Therapy Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Purpura Therapy Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Purpura Therapy Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Purpura Therapy Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Purpura Therapy Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Purpura Therapy Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Purpura Therapy Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Purpura Therapy Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Purpura Therapy Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Purpura Therapy Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Purpura Therapy Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Purpura Therapy Drugs Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Purpura Therapy Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Purpura Therapy Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Purpura Therapy Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bristol-Myers Squibb Company Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Bristol-Myers Squibb Company Purpura Therapy Drugs Product Offered
Table 94. Bristol-Myers Squibb Company Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Bristol-Myers Squibb Company Main Business
Table 96. Bristol-Myers Squibb Company Latest Developments
Table 97. Pfizer Inc Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Inc Purpura Therapy Drugs Product Offered
Table 99. Pfizer Inc Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Pfizer Inc Main Business
Table 101. Pfizer Inc Latest Developments
Table 102. GlaxoSmithKline Plc Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. GlaxoSmithKline Plc Purpura Therapy Drugs Product Offered
Table 104. GlaxoSmithKline Plc Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. GlaxoSmithKline Plc Main Business
Table 106. GlaxoSmithKline Plc Latest Developments
Table 107. Novartis AG Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis AG Purpura Therapy Drugs Product Offered
Table 109. Novartis AG Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Novartis AG Main Business
Table 111. Novartis AG Latest Developments
Table 112. Hovione Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Hovione Purpura Therapy Drugs Product Offered
Table 114. Hovione Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Hovione Main Business
Table 116. Hovione Latest Developments
Table 117. Sanofi Winthrop Industrie S.A. Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Product Offered
Table 119. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. Sanofi Winthrop Industrie S.A. Main Business
Table 121. Sanofi Winthrop Industrie S.A. Latest Developments
Table 122. Hoffman-L Roche Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Hoffman-L Roche Purpura Therapy Drugs Product Offered
Table 124. Hoffman-L Roche Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. Hoffman-L Roche Main Business
Table 126. Hoffman-L Roche Latest Developments
Table 127. Amgen Inc Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Amgen Inc Purpura Therapy Drugs Product Offered
Table 129. Amgen Inc Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. Amgen Inc Main Business
Table 131. Amgen Inc Latest Developments
Table 132. Grifols Biologicals Inc Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Grifols Biologicals Inc Purpura Therapy Drugs Product Offered
Table 134. Grifols Biologicals Inc Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Grifols Biologicals Inc Main Business
Table 136. Grifols Biologicals Inc Latest Developments
Table 137. Ablynx NV Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Ablynx NV Purpura Therapy Drugs Product Offered
Table 139. Ablynx NV Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. Ablynx NV Main Business
Table 141. Ablynx NV Latest Developments
Table 142. Biogen Inc Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Biogen Inc Purpura Therapy Drugs Product Offered
Table 144. Biogen Inc Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. Biogen Inc Main Business
Table 146. Biogen Inc Latest Developments
Table 147. KM Biologics Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. KM Biologics Purpura Therapy Drugs Product Offered
Table 149. KM Biologics Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 150. KM Biologics Main Business
Table 151. KM Biologics Latest Developments
Table 152. Lee's Pharmaceutical Holdings Ltd Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Product Offered
Table 154. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 155. Lee's Pharmaceutical Holdings Ltd Main Business
Table 156. Lee's Pharmaceutical Holdings Ltd Latest Developments
Table 157. Omeros Corp Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Omeros Corp Purpura Therapy Drugs Product Offered
Table 159. Omeros Corp Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 160. Omeros Corp Main Business
Table 161. Omeros Corp Latest Developments
Table 162. Takeda Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Takeda Purpura Therapy Drugs Product Offered
Table 164. Takeda Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 165. Takeda Main Business
Table 166. Takeda Latest Developments
Table 167. Roch Basic Information, Purpura Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 168. Roch Purpura Therapy Drugs Product Offered
Table 169. Roch Purpura Therapy Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 170. Roch Main Business
Table 171. Roch Latest Developments
List of Figures
Figure 1. Picture of Purpura Therapy Drugs
Figure 2. Purpura Therapy Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Purpura Therapy Drugs Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Purpura Therapy Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Purpura Therapy Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Allergic Purpura
Figure 10. Product Picture of Thrombocytopenic Purpura
Figure 11. Global Purpura Therapy Drugs Sales Market Share by Type in 2021
Figure 12. Global Purpura Therapy Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Purpura Therapy Drugs Consumed in Hospital Use
Figure 14. Global Purpura Therapy Drugs Market: Hospital Use (2017-2022) & (K Pcs)
Figure 15. Purpura Therapy Drugs Consumed in Clinic Use
Figure 16. Global Purpura Therapy Drugs Market: Clinic Use (2017-2022) & (K Pcs)
Figure 17. Purpura Therapy Drugs Consumed in Household
Figure 18. Global Purpura Therapy Drugs Market: Household (2017-2022) & (K Pcs)
Figure 19. Purpura Therapy Drugs Consumed in Other
Figure 20. Global Purpura Therapy Drugs Market: Other (2017-2022) & (K Pcs)
Figure 21. Global Purpura Therapy Drugs Sales Market Share by Application (2017-2022)
Figure 22. Global Purpura Therapy Drugs Revenue Market Share by Application in 2021
Figure 23. Purpura Therapy Drugs Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Purpura Therapy Drugs Revenue Market Share by Company in 2021
Figure 25. Global Purpura Therapy Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Purpura Therapy Drugs Revenue Market Share by Geographic Region in 2021
Figure 27. Global Purpura Therapy Drugs Sales Market Share by Region (2017-2022)
Figure 28. Global Purpura Therapy Drugs Revenue Market Share by Country/Region in 2021
Figure 29. Americas Purpura Therapy Drugs Sales 2017-2022 (K Pcs)
Figure 30. Americas Purpura Therapy Drugs Revenue 2017-2022 ($ Millions)
Figure 31. APAC Purpura Therapy Drugs Sales 2017-2022 (K Pcs)
Figure 32. APAC Purpura Therapy Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Europe Purpura Therapy Drugs Sales 2017-2022 (K Pcs)
Figure 34. Europe Purpura Therapy Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Purpura Therapy Drugs Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Purpura Therapy Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Americas Purpura Therapy Drugs Sales Market Share by Country in 2021
Figure 38. Americas Purpura Therapy Drugs Revenue Market Share by Country in 2021
Figure 39. United States Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Purpura Therapy Drugs Sales Market Share by Region in 2021
Figure 44. APAC Purpura Therapy Drugs Revenue Market Share by Regions in 2021
Figure 45. China Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Purpura Therapy Drugs Sales Market Share by Country in 2021
Figure 52. Europe Purpura Therapy Drugs Revenue Market Share by Country in 2021
Figure 53. Germany Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Purpura Therapy Drugs Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Purpura Therapy Drugs Revenue Market Share by Country in 2021
Figure 60. Egypt Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Purpura Therapy Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Purpura Therapy Drugs in 2021
Figure 66. Manufacturing Process Analysis of Purpura Therapy Drugs
Figure 67. Industry Chain Structure of Purpura Therapy Drugs
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...